Direkt zum Inhalt
Merck

DNA repair and replication proteins as prognostic markers in melanoma.

Histopathology (2012-10-02)
Liang Song, Tammy Robson, Tamasin Doig, Thomas Brenn, Marie Mathers, Ewan R Brown, Val Doherty, John M S Bartlett, Niall Anderson, David W Melton
ZUSAMMENFASSUNG

Elevated expression of DNA repair and replication genes has been reported in thick, non-fixed primary melanomas that subsequently went on to metastasize, when compared to non-recurrent primary tumours. This increased expression could contribute to the extreme resistance shown by melanoma to DNA-damaging chemotherapeutics. We have investigated the hypothesis that levels of key DNA repair and replication proteins are prognostic biomarkers in melanoma. We used a tissue microarray containing samples from all stages of melanomagenesis to investigate the hypothesis that levels of key DNA repair and replication proteins are prognostic biomarkers in a larger, more representative and readily available set of fixed primary melanomas. High expression of topoisomerase IIα (TOP2A), that relieves torsional stress during DNA replication, and XRCC5 (Ku80), required for DNA double-strand break repair, were associated with significantly worse survival. Two (XRCC5 and TOP2A) of seven DNA repair and replication proteins studied were prognostic for melanoma.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-RPA3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution